Winner

Healthcare - Emerging Corporates

Award Function

  • B0367_2015_0 B0367_2015_0
CMPOne Day(%)Weekly(%)Monthly(%)Quarterly(%)Half Yearly(%)Year(%)YTD(%)52 Weeks High52 Weeks Low
529.2 -51.66 -51.66 -51.66 -51.66 -51.66 -43.90 -44.36 1098.50 894.10
* Not adjusted for Corporate Action i.e. Bonus / Split / Dividend
Report DateResearch houseDescriptionRecoAt PriceTarget PriceUpSide
/DownSide
Download
3-Dec-17 Motilal Oswal Mylan/ Biocon received Trastuzumab approval in US Neutral 447 485 8.5
27-Oct-17 Nirmal Bang Sec Slowdown In Biosimilar Business As Well As Licensing Income Sell 360 308 -14.44
10-Oct-17 Nirmal Bang Sec USFDA Complete Response Letter To Mylan/Biocon's Pegfilgrastim Sell 344 246 -28.49
31-Jul-17 Isec Subdued Q1; biosimilars progress to hold key Hold 386 380 -1.55
28-Jul-17 Nirmal Bang Sec Revenues Below Expectations Sell 391 246 -37.08


Analyst Calls / Meets


Management Interviews

20-Nov-17 Kiran Mazumdar ..  
27-Oct-17 Kiran Mazumdar ..  
12-Jun-17 Kiran Muzumdar ..  
28-Apr-17 Kiran Mazumdar ..  
24-Mar-17 Kiran Mazumdar ..  

Investor Presentations

30-Jun-17 Investor/Anal...
28-Apr-17 Investor/Anal...
01-Feb-17 Investor/Anal...
30-Nov-16 Investor/Anal...
30-Jun-16 Investor/Anal...

Annual Reports
Source: Reportjunction.com

2016-17  
2015-16  
2014-15  
2013-14  
2012-13  

Research Showcase

03-Dec-17
Motilal Oswal -..
Download
27-Oct-17
Nirmal Bang Sec..
Download
10-Oct-17
Nirmal Bang Sec..
Download
31-Jul-17
Isec - Quarter ..
Download
28-Jul-17
Nirmal Bang Sec..
Download

Results

27-Jul-17 Results
27-Apr-17 Results
24-Jan-17 Results
20-Oct-16 Results
21-Jul-16 Results

AGM/EGM/Board Meetings

08-Dec-17 - POM
26-Oct-17 - Quarterly Results
28-Jul-17 - AGM
27-Jul-17 - Quarterly Results
07-Jun-17 - POM

Company Announcements

21-Sep-17
12:00 AM
Analyst / Investor Meet - Intimation Company Update Annoucements
18-Sep-17
12:00 AM
Press Release / Media Release Company Update Annoucements
15-Sep-17
12:00 AM
Analyst / Investor Meet - Intimation Company Update Annoucements
08-Sep-17
12:00 AM
Analyst / Investor Meet - Intimation Company Update Annoucements
30-Aug-17
12:00 AM
Press Release / Media Release Company Update Annoucements

RB Model Portfolio


Press Release

25-Oct-17 Press Release
10-Oct-17 Press Release
18-Sep-17 Press Release
13-Jul-17 Press Release
05-May-17 Press Release

 

Credit Ratings

12-Jan-17 Short-Term Rating ICRA A1+ Reaffirmed
12-Jan-17 Long-Term Rating [ICRA]AA+ (Stable) Reaffirmed
11-Aug-16 Short-Term Rating CRISIL A1+ Reaffirmed
11-Aug-16 Long-Term Rating CRISIL AA+/Stable Reaffirmed
08-Sep-15 Short-Term Rating ICRA A1+ Reaffirmed

Archived Documents

No Archieved Transcript.